Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Jochen Weigt, Jörn M. Schattenberg et al.|Journal of Hepatology|2022Cited by 26
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 InfectionsJulia Dietz, F. Kocheise, Ulrich Spengler et al.|Clinical Gastroenterology and Hepatology|2019Cited by 13
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, R. Zachoval, Christiana Graf et al.|JHEP Reports|2024Cited by 8